Henry Schein
Henry Schein, Inc., a leading global provider of healthcare products and services, is headquartered in the United States. Founded in 1932, the company has established a strong presence in the dental, medical, and veterinary sectors, serving healthcare professionals across North America, Europe, and Asia. With a diverse portfolio that includes dental supplies, medical equipment, and practice management software, Henry Schein is renowned for its commitment to innovation and customer service. The company has achieved significant milestones, including its recognition as one of the Fortune 500 and its consistent ranking among the top healthcare distributors globally. Henry Schein's unique approach combines comprehensive product offerings with tailored solutions, making it a trusted partner for healthcare providers seeking to enhance patient care and operational efficiency.
DitchCarbon Score
How does Henry Schein's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Henry Schein's score of 72 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Henry Schein's reported carbon emissions
In 2023, Henry Schein, Inc. reported total carbon emissions of approximately 834,000,000 kg CO2e, comprising 58,304,000 kg CO2e from Scope 1, 24,177,000 kg CO2e from Scope 2, and a significant 776,259,000 kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its carbon footprint, aiming for a 42% reduction in Scope 1 emissions by 2030 from a 2022 baseline, and a long-term goal of a 90% reduction by 2050. Additionally, Henry Schein is committed to achieving net-zero emissions across all scopes by 2050, with interim targets including a 51.6% reduction in Scope 3 emissions per million USD value added by 2030. The company is also focused on increasing its sourcing of renewable electricity from 0% in 2022 to 100% by 2030. These commitments align with the Science-Based Targets initiative (SBTi) and reflect Henry Schein's dedication to sustainable practices within the healthcare sector. The emissions data and reduction targets are not cascaded from any parent organization, indicating that they are independently reported by Henry Schein, Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 48,846,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Henry Schein is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
